SI
ABBV icon

Seeds Investor’s AbbVie ABBV Stock Holding History

Seeds Investor’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Buy
4,761
+39
+0.8% +$8.65K 0.14% 122
2025
Q4 		$1.08M Buy
4,722
+3,115
+194% +$710K 0.21% 79
2025
Q3 		$372K Buy
1,607
+9
+0.6% +$1.83K 0.08% 155
2025
Q2 		$297K Sell
1,598
-44
-3% -$8.18K 0.07% 180
2025
Q1 		$344K Sell
1,642
-322
-16% -$62.6K 0.1% 151
2024
Q4 		$349K Sell
1,964
-97
-5% -$17.8K 0.1% 150
2024
Q3 		$407K Buy
+2,061
New +$385K 0.15% 121

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seeds Investor's ABBV Position: Q1 2026 in Review

Seeds Investor increased its AbbVie (ABBV) stake by 0.83% in Q1 2026, buying an estimated $8.65K and bringing the position to 4,761 shares worth $1M. The position accounts for 0.14% of the portfolio, ranked #122.

Seeds Investor first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.08M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Seeds Investor held 4,761 shares of AbbVie worth $1M as of Q1 2026.
  • Seeds Investor bought 39 AbbVie shares in Q1 2026, an estimated $8.65K.
  • AbbVie made up 0.14% of Seeds Investor's portfolio in Q1 2026, its #122 holding.
  • Seeds Investor first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Seeds Investor's AbbVie position peaked at $1.08M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Seeds Investor's 13F filing for Q1 2026, filed 11 May 2026.